Publications:  Prof Alexandra Lansky

BAUMBACH AJ(2018). Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lancet vol. 392, 1117-1126.

Lansky AJ, Messé SR, Brickman AM, Dwyer M, Bart Van Der Worp H, Lazar RM, Pietras CG, Abrams KJ et al.(2018). Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. European Heart Journal vol. 39, (19) 1687-1697.

Brodmann M, Werner M, Brinton TJ, Illindala U, Lansky A, Jaff MR, Holden A(2017). Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions. Journal of the American College of Cardiology vol. 70, (7) 908-910.

Lansky AJ, Messé SR, Brickman AM, Dwyer M, van der Worp HB, Lazar RM, Pietras CG, Abrams KJ et al.(2017). Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. Journal of the American College of Cardiology vol. 69, (6) 679-691.

Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ et al.(2016). Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial). American Journal of Cardiology vol. 118, (10) 1519-1526.

Lansky AJ, Ng VG(2016). What the clinical event committee does not see when it comes to stent thrombosis. Circulation: Cardiovascular Interventions vol. 9, (5)

Lansky AJ, Kastrati A, Edelman ER, Parise H, Ng VG, Ormiston J, Wijns W, Byrne RA(2016). Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies). American Journal of Cardiology vol. 117, (4) 532-538.

Spatz ES, Curry LA, Masoudi FA, Zhou S, Strait KM, Gross CP, Curtis JP, Lansky AJ et al.(2015). The variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) classification system: A taxonomy for young women with acute myocardial infarction. Circulation vol. 132, (18) 1710-1718.

Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK et al.(2015). A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: Results from the DEFLECT III trial. European Heart Journal vol. 36, (31) 2070-2078.

Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE et al.(2014). Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: Results from the FREEDOM trial. Journal of the American College of Cardiology vol. 64, (12) 1189-1197.